At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Study of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT)

Clinical Trial Title: 
CCTG MA.39: TAILOR RT: A randomized trial of regional radiotherapy in biomarker low risk node positive breast cancer.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Parul Barry, MD
Clinical Trial Protocol Description: 

Women with node positive breast cancer normally will receive endocrine therapy and some may receive chemotherapy to help prevent the cancer from coming back. Many women will also receive radiotherapy to the whole breast/chest area and the surrounding lymph glands (called regional radiotherapy). No one really knows whether patients with low risk breast cancer need to receive regional radiotherapy. Some women may be getting regional radiotherapy who do not need it. These women may be exposed to the side effects of their treatment without benefit.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have newly diagnosed histologically proven invasive carcinoma of the breast with no evidence of metastases.
  • Are at least 40 years old.
  • Patients may or may not have had adjuvant chemotherapy.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Breast Cancer
Contact Phone: 
(312) 226-2371
Contact Name: 
Jean Gibson, RN, BSN